Immunic eyes Phase 3 after MS disability gains in Phase 2 CALLIPER trial

By Proactive Investors / May 07, 2025 / www.youtube.com / Article Link


Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt talked with Proactive's Stephen Gunnion about the latest results from the ...

Recent News

Base metals outperform over past month
April 06, 2026 / www.canadianminingreport.com

Gold stocks rise for second week
April 06, 2026 / www.canadianminingreport.com

Mining ETF outflows not severe versus December 2025-January 2026 inflows
March 30, 2026 / www.canadianminingreport.com

Gold stocks rebound as metal declines
March 30, 2026 / www.canadianminingreport.com

Energy outperforms gold and tech for first time in years
March 23, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok